Nitazoxanide + Ofloxacin Tablet Franchise in Ahmedabad

Antimicrobial & Antiprotozoal Therapy Supplier in Mumbai

Nitanap O Tablet Distributor in Delhi

Gastrointestinal Infection Tablet Franchise Opportunity in Bangalore

Bacterial & Protozoal Infection Tablet Stockist in Hyderabad
Nitazoxanide + Ofloxacin Export & Manufacturing in Chandigarh

Home/Products /nitazoxanide-500mg-ofloxacin-200mg-tablet

About the Product

Description


Nitanap O Tablet contains Nitazoxanide 500mg + Ofloxacin 200mg, a combination therapy designed for the treatment of gastrointestinal infections caused by both protozoal and bacterial pathogens. It helps in rapid eradication of infection, relieving associated symptoms like diarrhea, abdominal pain, and dysentery.

Nitazoxanide works by inhibiting the anaerobic energy metabolism of protozoa, while Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase, preventing bacterial replication. Together, they provide broad-spectrum coverage for mixed infections.

For distributors and healthcare suppliers, Nitanap O Tablet is a high-demand combination therapy, frequently used in hospitals, clinics, and community healthcare settings. Gastrointestinal infections remain prevalent, ensuring consistent year-round demand.

Adding Nitanap O Tablet to your antimicrobial and antiprotozoal therapy segment creates strong opportunities in pharmacies, hospitals, travel clinics, export markets, and third-party manufacturing. Its proven efficacy, broad therapeutic coverage, and prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, abdominal pain, diarrhea, headache, or dizziness. Rarely, allergic reactions, tendonitis, liver dysfunction, or hypersensitivity reactions may occur. Patients should consult a doctor if severe or persistent symptoms develop.

Nitanap 500 Tablet is indicated for the treatment of intestinal protozoal and helminthic infections, including amoebiasis, giardiasis, cryptosporidiosis, and other parasitic gastrointestinal infections, as directed by a healthcare professional.

Nitanap O Tablet should be taken exactly as prescribed, and the full course must be completed to ensure effective eradication of infection. Inform your doctor if you have liver or kidney disease, a history of tendon disorders, or if you are pregnant or breastfeeding before starting therapy. Avoid taking antacids containing magnesium or aluminum close to the dose of this medication.

Store Nitanap O Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and ensure the blister pack is intact. Do not use the tablet beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Nitazoxanide 500mg + Ofloxacin 200mg Tablet in the PCD pharma franchise market?

Nitazoxanide 500mg + Ofloxacin 200mg Tablet has strong demand in the anti-infective, gastroenterology, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on gastrointestinal and infectious disease portfolios.

Why should medical distributors include Nitazoxanide 500mg + Ofloxacin 200mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for gastrointestinal infection management under medical supervision. Nitazoxanide 500mg is an antiparasitic and antiprotozoal agent used against certain intestinal parasitic infections Ofloxacin 200mg is a fluoroquinolone antibiotic effective against a broad range of susceptible bacterial infections This combination is commonly prescribed for the management of mixed gastrointestinal infections, infectious diarrhea, gastroenteritis, and intestinal infections as advised by healthcare professionals Helps address both bacterial and protozoal pathogens when clinically indicated Frequently utilized in gastroenterology clinics, hospitals, and general medical practice Requires prescription-based use and adherence to the complete treatment course Widely prescribed by gastroenterologists and general physicians This strengthens a comprehensive anti-infective and gastrointestinal care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Nitazoxanide 500mg + Ofloxacin 200mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand, seasonal sales opportunities, repeat purchases, reliable supply chain support, and attractive margins in the anti-infective segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.